Artery Headlines
2017-06-19
We found that all 14 startups had secured financing, raising a total of $276.82 million, with UK-based BenevolentAI alone accounting for $100 million. The company has one drug candidate scheduled to enter Phase 2b clinical trials in mid-2017, and it sold two other investigational drug candidates to a U.S. pharmaceutical company for $800 million.
450,000 Hemodialysis Patients, a RMB 33.5 Billion Market: Will You Take Your Share?
2017-06-20
What is the current state of development for independent blood dialysis centers in China? Which companies and institutions are involved, what stages of development have they reached, and what are the major challenges they face? By analyzing domestic dialysis data and interviewing several leading private independent hemodialysis service providers in China, VCBeat presents a detailed overview of the current landscape and development trends in this niche sector, while uncovering investment opportunities.
2017-06-21
Diabetes management is a key R&D focus for many digital health companies. Major U.S. medical device manufacturers, such as Medtronic and DexCom, are also devoting increasing resources to smartphone applications and consumer-grade connected devices. Consequently, at this year’s ADA Scientific Sessions, technology and digital health companies demonstrated significant potential that cannot be overlooked.
VCBeat (WeChat ID: vcbeat) has compiled and translated relevant reports from foreign media outlets such as MobileHealthNews, with a particular focus on the latest achievements announced by participating digital health companies, offering you a glimpse into the cutting-edge advancements of digital health in the field of diabetes.
2017-06-22
VCBeat·VBInsight gathered first-hand information on independent hemodialysis centers in China by reviewing domestic and international industry data and interviewing heads of several leading private independent hemodialysis service providers. After two months of interviews and data analysis, VBInsight completed this report. This article highlights key insights from industry experts and summarizes critical considerations for establishing independent hemodialysis centers.
2017-06-23
In the construction of the medical consortium at the First Affiliated Hospital of Chongqing Medical University, it is evident that the medical consortium serves as a crucial measure to promote the vertical integration of medical resources. During its formation and implementation, the interests of various participating medical institutions are closely intertwined. By clarifying the strategic interactions among key stakeholders—such as the game-theoretic dynamics between core hospitals and member hospitals regarding assistance and cooperation choices, and the competitive interplay between non-member hospitals and the medical consortium—it is possible to explore a sustainable development path for the effective operation of medical consortia. This can be achieved by improving compensation and supervision mechanisms, enhancing primary healthcare service capabilities, fostering orderly competition among medical institutions within the region, and refining corporate governance structures.
Active Company

Capital Dynamics
This Week in the Domestic and International Medical FieldsTotal15StartFinancing Event.



Policy Updates

Event Updates

Industry Trends
Hot Topics

Listed Company

Frontiers of Technology

In-Depth Report

Detailed weekly report content is available in the VCBeat knowledge base!
